The purpose of Core B is to provide a Program for Pilot/Feasibility Studies in association with the HCV Persistence Study Group (HPSG). Core B will be located in Dr. Chung's laboratory/office complex at the Liver Center/Gastrointestinal Division of Massachusetts General Hospital. The main goals of Core B are to administer and oversee the Pilot/Feasibility Studies Program of the HPSG. The specific tasks of Core B will be to: (a) solicit applications for the PES program annually;(b) provide a mechanism for scientific peer review of the PES applications;(c) monitor research progress;and (d) to organize an annual scientific symposium (in conjunction with the annual visit of the U19 External Scientific Advisory Group) for PES awardees to present their research findings;In this regard. Core B will be closely intertwined with the operations of Core A (Administrative), as there will be substantive thematic overlap between the two cores. It is expected that one of the key benefits of Core B's activities will be to foster additional scientific interactions between members of the local scientific community and the PIs of the HPSG program.
CORE B is an essential structure that will support pilot and feasibility projects that enhance and enrich the scope and quality ofthe science ofthe main Projects and Cores ofthe Hepatitis C Persistence Study Group, in so doing fostering new interactions with HPSG Pis.
|Rowe, Ian A; Tully, Damien C; Armstrong, Matthew J et al. (2016) Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation. Liver Transpl 22:287-97|
|Fergusson, J R; HÃ¼hn, M H; Swadling, L et al. (2016) CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut. Mucosal Immunol 9:401-13|
|Attanasio, John; Wherry, E John (2016) Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity 44:1052-68|
|Llibre, Alba; LÃ³pez-MacÃas, Constantino; Marafioti, Teresa et al. (2016) LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol 196:2085-94|
|Kurioka, Ayako; Walker, Lucy J; Klenerman, Paul et al. (2016) MAIT cells: new guardians of the liver. Clin Transl Immunology 5:e98|
|van Wilgenburg, Bonnie; Scherwitzl, Iris; Hutchinson, Edward C et al. (2016) MAIT cells are activated during human viral infections. Nat Commun 7:11653|
|Jeffery, Hannah C; van Wilgenburg, Bonnie; Kurioka, Ayako et al. (2016) Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. J Hepatol 64:1118-27|
|Kelly, Christabel; Swadling, Leo; Capone, Stefania et al. (2016) Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans. Hepatology 63:1455-70|
|Chusri, Pattranuch; Kumthip, Kattareeya; Hong, Jian et al. (2016) HCV induces transforming growth factor Î²1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep 6:22487|
|Swadling, Leo; Halliday, John; Kelly, Christabel et al. (2016) Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines (Basel) 4:|
Showing the most recent 10 out of 128 publications